These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 21676369

  • 41. Association of N-terminal pro-brain natriuretic peptide with the severity of coronary artery disease in patients with normal left ventricular ejection fraction.
    Wu N, Ma F, Guo Y, Li X, Liu J, Qing P, Xu R, Zhu C, Jia Y, Liu G, Dong Q, Jiang L, Li J.
    Chin Med J (Engl); 2014; 127(4):627-32. PubMed ID: 24534213
    [Abstract] [Full Text] [Related]

  • 42. Usefulness of High-Sensitivity Cardiac Troponin T for the Identification of Outlier Patients With Diffuse Coronary Atherosclerosis and Low-Risk Factors.
    Magnoni M, Masson S, Andreini D, Moccetti T, Modena MG, Canestrari M, Berti S, Casolo G, Gabrielli D, Marraccini P, Pontone G, Latini R, Maggioni AP, Maseri A, CAPIRE Study Group.
    Am J Cardiol; 2016 May 01; 117(9):1397-404. PubMed ID: 26976791
    [Abstract] [Full Text] [Related]

  • 43. Usefulness of preprocedural N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during stent implantation in patients with ST-segment elevation acute myocardial infarction.
    Hong SN, Ahn Y, Hwang SH, Yoon NS, Lee SR, Moon JY, Kim KH, Hong YJ, Park HW, Kim JH, Jeong MH, Cho JG, Park JC, Kang JC.
    Am J Cardiol; 2007 Aug 15; 100(4):631-4. PubMed ID: 17697819
    [Abstract] [Full Text] [Related]

  • 44. The severity of coronary artery disease and reversible ischemia revealed by N-terminal pro-brain natriuretic peptide in patients with unstable angina and preserved left ventricular function.
    Xu L, Qian W, Li W, Liu J, He H, Li G, Cao Y, Yu Y.
    Peptides; 2014 Feb 15; 52():143-8. PubMed ID: 24412773
    [Abstract] [Full Text] [Related]

  • 45. Plasma B-type natriuretic peptide levels reflect the presence and severity of stable coronary artery disease in chronic haemodialysis patients.
    Niizuma S, Iwanaga Y, Yahata T, Goto Y, Kita T, Miyazaki S, Nakahama H.
    Nephrol Dial Transplant; 2009 Feb 15; 24(2):597-603. PubMed ID: 18762474
    [Abstract] [Full Text] [Related]

  • 46. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis.
    Gravning J, Smedsrud MK, Omland T, Eek C, Skulstad H, Aaberge L, Bendz B, Kjekshus J, Mørkrid L, Edvardsen T.
    Am Heart J; 2013 May 15; 165(5):716-24. PubMed ID: 23622908
    [Abstract] [Full Text] [Related]

  • 47. N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease.
    Ndrepepa G, Kastrati A, Braun S, Mehilli J, Niemöller K, von Beckerath N, von Beckerath O, Vogt W, Schömig A.
    Am J Med; 2006 Apr 15; 119(4):355.e1-8. PubMed ID: 16564781
    [Abstract] [Full Text] [Related]

  • 48. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS, Gupta N, Sethi R, Puri A, Dwivedi SK, Saran RK, Puri VK.
    Indian Heart J; 2008 Apr 15; 60(6):536-42. PubMed ID: 19276492
    [Abstract] [Full Text] [Related]

  • 49. [Usefulness of high-sensitivity CRP increases during circadian rhythm for prediction of long-term cardiovascular events in patients with stable coronary artery disease].
    Koç M, Sahin DY, Uysal OK, Karaarslan O, Dönmez E, Abalı G, Batur MK.
    Turk Kardiyol Dern Ars; 2011 Oct 15; 39(7):568-75. PubMed ID: 21983767
    [Abstract] [Full Text] [Related]

  • 50. High-sensitivity cardiac troponin T and copeptin assays to improve diagnostic accuracy of exercise stress test in patients with suspected coronary artery disease.
    Liebetrau C, Gaede L, Dörr O, Hoffmann J, Wolter JS, Weber M, Rolf A, Hamm CW, Nef HM, Möllmann H.
    Eur J Prev Cardiol; 2015 Jun 15; 22(6):684-92. PubMed ID: 24699335
    [Abstract] [Full Text] [Related]

  • 51. N-terminal pro-brain natriuretic peptide and high-sensitivity troponin in the evaluation of acute chest pain of uncertain etiology. A PITAGORAS substudy.
    Sanchis J, Bardají A, Bosch X, Loma-Osorio P, Marín F, Sánchez PL, Calvo F, Avanzas P, Hernández C, Serrano S, Carratalá A, Barrabés JA.
    Rev Esp Cardiol (Engl Ed); 2013 Jul 15; 66(7):532-8. PubMed ID: 24776201
    [Abstract] [Full Text] [Related]

  • 52. Influence of cigarette smoking on cardiac biomarkers: the Atherosclerosis Risk in Communities (ARIC) Study.
    Nadruz W, Gonçalves A, Claggett B, Querejeta Roca G, Shah AM, Cheng S, Heiss G, Ballantyne CM, Solomon SD.
    Eur J Heart Fail; 2016 Jun 15; 18(6):629-37. PubMed ID: 27030444
    [Abstract] [Full Text] [Related]

  • 53. B-type natriuretic peptide as an independent predictor of coronary disease extension in non-ST elevation coronary syndromes with preserved systolic function.
    Palazzuoli A, Caputo M, Fineschi M, Navarri R, Calabrò A, Cameli M, Campagna MS, Franci B, Pierli C, Nuti R, Maisel A.
    Eur J Prev Cardiol; 2012 Jun 15; 19(3):366-73. PubMed ID: 21464097
    [Abstract] [Full Text] [Related]

  • 54. Potential predictors for mental stress-induced myocardial ischemia in patients with coronary artery disease.
    Liu MY, Yang Y, Zhang LJ, Pu LH, He DF, Liu JY, Hafeez A, Ding YC, Ma H, Geng QS.
    Chin Med J (Engl); 2019 Jun 20; 132(12):1390-1399. PubMed ID: 31205095
    [Abstract] [Full Text] [Related]

  • 55. Coronary microvascular dysfunction and diastolic load correlate with cardiac troponin T release measured by a highly sensitive assay in patients with nonischemic heart failure.
    Takashio S, Yamamuro M, Izumiya Y, Sugiyama S, Kojima S, Yamamoto E, Tsujita K, Tanaka T, Tayama S, Kaikita K, Hokimoto S, Ogawa H.
    J Am Coll Cardiol; 2013 Aug 13; 62(7):632-40. PubMed ID: 23644085
    [Abstract] [Full Text] [Related]

  • 56. Is N-terminal pro B-type natriuretic peptide (NT-proBNP) a useful screening test for angiographic findings in patients with stable coronary disease?
    Kragelund C, Grønning B, Omland T, Køber L, Strande S, Steffensen R, Hildebrandt P.
    Am Heart J; 2006 Mar 13; 151(3):712.e1-712.e7. PubMed ID: 16504637
    [Abstract] [Full Text] [Related]

  • 57. Association of GDF-15, hs-cTnT and NT-proBNP with coronary artery disease in patients undergoing elective angiography.
    Souaid T, Hijazi Z, Barakett V, Sarkis A, Kadri Z, Batra G, Lindbäck J, Abdelmassih T, Azar RR.
    Future Cardiol; 2022 Aug 13; 18(8):635-646. PubMed ID: 35678322
    [Abstract] [Full Text] [Related]

  • 58. Differential associations of cardiac troponin T and cardiac troponin I with coronary artery pathology and dynamics in response to short-duration exercise.
    Tveit SH, Cwikiel J, Myhre PL, Omland T, Berge E, Seljeflot I, Flaa A.
    Clin Biochem; 2021 Feb 13; 88():23-29. PubMed ID: 33245871
    [Abstract] [Full Text] [Related]

  • 59. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
    Buchner S, Debl K, Barlage S, Griese D, Fredersdorf S, Jeron A, Lubnow M, Müller T, Muders F, Holmer S, Riegger GA, Luchner A.
    Clin Chem Lab Med; 2010 Jun 13; 48(6):875-81. PubMed ID: 20441480
    [Abstract] [Full Text] [Related]

  • 60. Different characteristics of cardiac biomarkers to decide and predict the culprit lesions in patients with suspicious acute coronary syndrome.
    Kitamura M, Hata N, Takayama T, Hirayama A, Ogawa M, Yamashina A, Mera H, Yoshino H, Nakamura F, Seino Y.
    Heart Vessels; 2016 Jun 13; 31(6):907-17. PubMed ID: 26081026
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.